Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma

Cancer Research

Volumn 57, Issue 20, 1997, Pages 4608-4614

  Dreyling, Martin H ^a   Bullinger, Lars ^b   Ott, German ^c   Stilgenbauer, Stephan ^b   Müller Hermelink, Hans K ^c   Bentz, Martin ^b   Hiddemann, Wolfgang ^a   Döhner, Hartmut ^b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1;

ARTICLE; CELL PROLIFERATION; CHROMOSOME TRANSLOCATION; GENE ACTIVATION; GENE DELETION; GENE MUTATION; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; MALIGNANT TRANSFORMATION; MANTLE CELL LYMPHOMA; MOLECULAR CLONING; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ANIMALS; CELL CYCLE; CHROMOSOME ABERRATIONS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 14; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P16; GENE DELETION; GENES, P16; GENES, RETINOBLASTOMA; HUMANS; IMMUNOPHENOTYPING; LYMPHOMA, SMALL CLEAVED-CELL, DIFFUSE; MICE; MICE, TRANSGENIC; RETINOBLASTOMA PROTEIN; TRANSLOCATION, GENETIC;

EID: 0030882326     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Hunter, T., and Pines, J. Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell, 79: 573-582, 1994
2. Hirama, T., and Koeffler, H. P. Role of the cyclin dependent kinase inhibitors in the development of cancer. Blood, 86: 841-854, 1995.
3. El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. WAFI, a potential mediator of p53 tumor suppression. Cell, 75: 817-825, 1993.
4. Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., and Beach, D. p21 is a universal inhibitor of cyclin kinases. Nature (Lond.), 366: 701-704, 1993.
5. Weinberg, R. B. The retinoblastoma protein and cell cycle control. Cell, 81: 323-330, 1995.
6. Dowdy, S. F., Hinds, P. W., Louie, K., Reed, S. I., Arnold, A., and Weinberg, R. A. Physical interaction of the retinoblastoma protein with human cyclins. Cell, 73: 499-511, 1993.
7. Nevins, J. R. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science (Washington DC), 258: 424-429, 1992.
8. 1 phase in rodent fibroblasts. Genes Dev., 7: 1559-1571, 1993.
9. INK4B is a potential effector of TGF-β induced cell cycle arrest. Nature (Lond.), 371: 257-261, 1994.
10. Kamb, A., Gruis, N. A., Weaver, F. J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R., III, Johnson, B. E., and Skolnick, M. H. A cell cycle regulator potentially involved in genesis of many tumor types. Science (Washington DC), 264: 436-440, 1994.
11. Serrano, M., Hannon, G. J., and Beach, D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature (Lond.), 366: 704-707, 1993.
12. Bartkova, J., Lukas, J., Guldberg, P., Alsner, J., Kirkin, A. F., Zeuthen, J., and Bartek, J. The p16-cyclin D/cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis. Cancer Res., 56: 5475-5483, 1996.
13. He, J., Allen, J. R., Collins, V. P., Allalunis-Turner, M. J., Godbout, R., Day, R. S., III, and James, C. D. CDK4 amplification is an alternative mechanism to p16 homozygous deletion in glioma cell lines. Cancer Res., 54: 5804-5807, 1994.
14. Michalides, R., Van Veelen, N., Hart, A., Loftus, B., Wientjens, E., and Balm, A. Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer (Phila.), 55: 975-978, 1995.
15. INK4B, p53, and Rb genes in primary lymphoid malignancies. Blood, 87: 4949-4958, 1996.
16. Quesnel, B., Preudhomme, C., Philippe, N., Vanrumbeke, M., Dervite, I., Lai, J. L., Bauters, F., Wattel, E., and Fenaux, P. p16 homozygous deletions in acute lymphoblastic leukemia. Blood, 85: 657-663, 1994.
17. INK4A expression in primary lung cancers and cell lines. Cancer Res., 55: 505-509, 1995.
18. Schauer, I. E., Siriwardana, S., Langan, T. A., and Sclafani, R. I. Cyclin D1 overexpression vs. retinoblastoma inactivation: implications for growth control evasion in non-small and small cell lung cancer. Proc. Natl. Acad. Sci. USA, 91: 7827-7831, 1994.
19. Bosch, F., Jares, P., Campo, E., Lopez-Guillermo, A., Piris, M. A., Villamor, N., Tassies, D., Jaffe, E. S., Montserrat, E., Rozman, C., and Cardesa, A. Prad-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma. Blood, 84: 2726-2732, 1994.
20. de Boer, C. J., van Krieken, J. H. M., Kluin-Nelemans, H. C., Kluin, P. M., and Schuuring, E. Cyclin D1 messenger RNA overexpression as a marker for mantle cell lymphoma. Oncogene, 10: 1833-1840, 1995.
21. Ott, M. M., Helbing, A., Ott, G., Bartek, J., Fischer, L., Dürr, A., Kreipe, H., and Müller-Hermelink, H. K. bcl-1 rearrangement and cyclin D1 protein expression in mantle cell lymphoma. J. Pathol., 179: 238-242, 1996.
22. Rosenberg, C., Wong, E., Petty, E., Bale, A., Tsujimoto, Y., Harris, N., and Arnold, A. Overexpression of PRAD1, a candidate BCL1 breakpoint region oncogene, in centrocytic lymphomas. Proc. Natl. Acad. Sci. USA, 88: 9638-9642, 1991.
23. Harris, N. L., Jaffe, E. S., Stein, H., Banks, P. M., Chan, J. K. C., Cleary, M. L., Delsol, G., Wolf-Peeters, C. D., Falini, B., Gatter, K. C., Grogan, T. M., Isaacson, P. G., Knowles, D. M., Mason, D. Y., Müller-Hermelink, H-K., Pileri, S. A., Piris, M. A., Ralfkiaer, E., and Warnke, R. A. A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood, 84: 1361-1392, 1994.
24. Weisenburger, D. D., and Armitage, J. O. Mantle cell lymphoma: an entity comes of age. Blood, 87: 4483-4494, 1996.
25. Tolksdorf, G., Stein, H., and Lennert, K. Morphological and immunological definition of a malignant lymphoma derived from germinal centre cells with cleaved nuclei (centrocytes). Br. J. Cancer, 41: 168-182, 1980.
26. Ott, G., Kalla, J., Ott, M., Schryen, B., Katzenberger, T., Müller, G. J., and Müller-Hermelink, H. K. Blastoid variant of mantle cell lymphoma: frequent BCL-1 rear-rangements at the MTC locus and tetraploid chromosome clones. Blood, 89: 1421-1429, 1997.
27. Ott, M. M., Ott, G., Kuse, R., Porowski, P., Gunzer, U., Feller, A. C., and Müller-Hermelink, H. K. The anaplastic variant of centrocytic lymphoma is marked by frequent rearrangements of the bcl-1 gene and high proliferation indices. Histopathology, 24: 329-334, 1994.
28. Lardelli, P., Bookman, M. A., Sundeen, J., Longo, D. L., and Jaffe, E. S. Lymphocytic lymphoma of intermediate differentiation. Morphologic and immunophenotypic spectrum and clinical correlation. Am. J. Surg. Pathol., 14: 752-763, 1990.
29. Fisher, R. I., Dahlberg, S., Nathwani, B. N., Banks, P. M., Miller, T. P., and Grogan, T. M. A clinical analysis of two indolent lymphoma entities: mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and moncytoid B-cell subcategories) - a southwest oncology group study. Blood, 85: 1075-1082, 1995.
30. Hiddemann, W., Brittinger, G., Tiemann, M., Parwareseh, R., Stein, H., Lister, A. T., Norton, A., Pittaluga, S., de Wolf-Peeters, C., van Hoof, A., Coiffier, B., Berger, F., Kluin-Nelemanns, H., van Krieken, H., Kluin, P., Cavalli, F., Roggero, E., Pedrinis, E., Montserrat, E., Piris, M. A., and Unterhalt, M. Clinical characteristics and response to chemotherapy of mantle cell lymphomas: results of a European survey. Blood, 88 (Suppl. 1): 674a, 1996.
31. Hiddemann, W., Unterhalt, M., Herrmann, R., Wöltjen, H-H., Kreuser, E-D., Trümper, L., Reuss, M., Terhardt-Karsten, E., Busch, M., Neubauer, A., Kaiser, U., Hanrath, R-D., Middeke, H., Helm, G., Freund, M., Stein, H., Tiemann, M., and Parwaresch, R. Mantle cell lymphomas have a more widespread disease and a slower response to chemotherapy as compared to follicle center lymphomas. Results of a prospective comparative analysis of the German Low Grade Lymphoma Study Group. JCO, in press, 1997.
32. Zucca, E., Roggero, E., Pinotti, G., Pedrinis, E., Cappella, C., Venco, A., and Cavalli, F. Pattern of survival in mantle cell lymphoma. Ann. Oncol., 6: 257-262, 1995.
33. Lovec, H., Grzeschiczek, A., Kowalski, M. B., and Möröy, T. Cyclin D1/bcl-1 cooperates with the myc genes in the generation of B-cell lymphoma in transgenic mice. EMBO J., 13: 3487-3495, 1994.
34. Bodrug, S. E., Warner, B. J., Bath, M. L., Lindemann, G. J., and Harris, A. W. Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphogenesis with the myc gene. EMBO J., 13: 2124-2130, 1994.
35. Bullinger, L., Schröder, M., Möller, P., Barth, T., Wilhelm, S., Stilgenbauer, S., Lichter, P., Bentz, M., and Döhner, H. Secondary chromosome abnormalities in t(11;14)(q13;q32) positive non-Hodgkin's lymphomas detected by fluorescence in situ hybridization. Ann. Hematol., 73 (Suppl. II): A124, 1996.
36. Stilgenbauer, S., Döhner, H., Bulgay-Mörschel, M., Weitz, S., Bentz, M., and Lichter, P. High frequency of monoallelic retinoblastoma gene deletion in B-cell chronic lymphoid leukemia shown by interphase cytogenetics. Blood, 81: 2118-2124, 1993.
37. Dreyling, M. H., Bohlander, S. K., Le Beau, M. M., and Olopade, O. I. Refined mapping of genomic rearrangements involving the short arm of chromosome 9 in acute lymphoblastic leukemia and other hematological malignancies. Blood, 86: 1931-1938, 1995.
38. Döhner, H., Stilgenbauer, S., James, M. R., Benner, A., Weilguni, T., Bentz, M., Fischer, K., Hunstein, W., and Lichter, P. 11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis. Blood, 89: 2516-2522, 1997.
39. Zucca, E., Stein, H., and Coiffier, B. European Lymphoma Task Force (ELFT): report of the workshop on Mantle Cell Lymphoma (MCL). Ann. Oncol., 5: 507-522, 1994.
40. Ott, M. M., Bartek, J., Duerr, A., Ott, G., Müller-Hermelink, H. K., and Kreipe, H. Mantle cell lymphomas with the t(11;14) exhibit protein expression of cyclin D1 and downregulation of cyclin D3 in contrast to normal B-lymphocytes. Ann. Hematol., 73 (Suppl. II): A131, 1996.
41. Le Beau, M. M. Cytogenetic analysis of hematological malignant diseases. In: M. J. Barch (ed.), The ACT Cytogenetics Laboratory Manual, pp. 395-445. New York: Raven Press Ltd., 1994.
42. Bohlander, S. K., Espinosa, R., III, Fernald, A. A., Rowley, J. D., Le Beau, M. M., and Diaz, M. Sequence-independent amplification and labeling of yeast artificial chromosomes for fluorescence in situ hybridization. Cytogenet. Cell Genet., 65: 108-110, 1994.
43. Stilgenbauer, S., Leupolt, E., Ohl, S., Weiß, G., Schröder, M., Fischer, K., Bentz, M., Lichter, P., and Döhner, H. Heterogeneity of deletions involving RB-1 and the D13S25 locus in B-cell chronic lymphocytic leukemia revealed by fluorescence in situ hybridization. Cancer Res., 55: 3475-3477, 1995.
44. Erickson, P., Gao, J., Chang, K. S., Look, T., Whisenant, E., Raimondi, S., Lasher, R., Trujillo, J., Rowley, J. D., and Drabkin, H. Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript AML1/ETO, with similarity to drosophila segmentation gene, runt. Blood, 80: 1825-1831, 1992.
45. Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E., Burger, P. C., Baylin, S. B., and Sidransky, D. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat. Med., 1: 686-692, 1995.
46. Ohnishi, H., Kawamura, M., Ida, K., Sheng, X. M., Hanada, R., Nobori, T., Yamamori, S., and Hayashi, Y. Homozygous deletions of p16/MTS1 gene are frequent but mutations are infrequent in childhood T-cell acute lymphoblastic leukemia. Blood, 86: 1269-1275, 1995.
47. INK4B1. Cancer Res., 56: 722-727, 1996.
48. WAF1 genes are associated with aggressive variants of mantle cell lymphomas. Blood, 89: 272-280, 1997.
49. Williams, M. E., Finkelstein, S. D., and Swerdlow, S. H. p53 mutations and cyclin-dependent kinase inhibitor p15 (MTS2) and p16 (MTS1, CDKN2) deletions in mantle cell lymphoma: association with extranodal disease. Ann. Oncol., 7 (Suppl. 3): 36, 1996.
50. Fizzotti, M., Cimino, G., Pisegna, S., Alimena, G., Quartarone, C., Mandelii, F., Pelicci, P. G., and Lo Coco, F. Detection of homozygous deletions of the cyclin-dependent kinase 4 inhibitor (p16) gene in acute lymphoblastic leukemia and association with adverse prognostic features. Blood, 85: 2685-2690, 1995.
51. Hernandez, L., Fest, T., Carzola, M., Teruya-Feldstein, J., Bosch, F., Peinado, M. A., Piris, M. A., Montserrat, E., Cardesa, A., Jaffe, E. S., Campo, E., and Raffeld, M. p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas. Blood, 86: 3351-3359, 1996.
52. Greiner, T. C., Moynihan, M. J., Chan, W. C., Lytle, D. M., Pederson, A., Anderson, J. R., and Weisenburger, D. D. p53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis. Blood, 87: 4302-4310, 1996.
53. Louie, D. C., Offit, K., Jaslow, R., Parza, N. Z., Murty, V. V. V. S., Schluger, A., and Chaganti, R. S. K. p53 overexpression as a marker of poor prognosis in mantle cell lymphomas with t(11;14)(q13;q32). Blood, 86: 2892-2899, 1995.
54. Lo Coco, F., Gaidano, G., Louie, D. C., Offit, K., Chaganti, R. S. K., and Dalla-Favera, R. p53 mutations are associated with histologic transformation of follicular lymphoma. Blood, 82: 2289-2295, 1993.
55. Jares, P. E., Pinyol, M., Bosch, F., Miquel, R., Fernandez, P. L., Sanchez-Beato, M., Soler, F., Perez-Losada, A., Nayach, I., Mallofre, C., Piris, M. A., Montserrat, E., and Cardesa, A. Expression of retinoblastoma gene product (pRB) in mantle cell lym-phomas. Am. J. Pathol., 148: 1591-1600, 1996.
56. Zukerberg, L. R., Benedict, W. F., Arnold, A., Dyson, N., Harlow, E., and Harris, N. L. Expression of the retinoblastoma protein in low-grade B-cell lymphoma: relationship to cyclin D1. Blood, 88: 268-276, 1996.